Lanean...
Oral 5‐aminosalicylic acid for induction of remission in ulcerative colitis
BACKGROUND: Oral 5‐aminosalicylic acid (5‐ASA) preparations were intended to avoid the adverse effects of sulfasalazine (SASP) while maintaining its therapeutic benefits. It was previously found that 5‐ASA drugs in doses of at least 2 g/day were more effective than placebo but no more effective than...
Gorde:
| Argitaratua izan da: | Cochrane Database Syst Rev |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley & Sons, Ltd
2020
|
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8189994/ https://ncbi.nlm.nih.gov/pubmed/32786164 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000543.pub5 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|